Safety and efficacy claims made by US businesses marketing purported stem cell treatments and exosome therapies
出版年份 2023 全文链接
标题
Safety and efficacy claims made by US businesses marketing purported stem cell treatments and exosome therapies
作者
关键词
-
出版物
Regenerative Medicine
Volume 18, Issue 10, Pages 781-793
出版商
Future Medicine Ltd
发表日期
2023-10-05
DOI
10.2217/rme-2023-0118
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Uncovering the gray zone: mapping the global landscape of direct-to-consumer businesses offering interventions based on secretomes, extracellular vesicles, and exosomes
- (2023) Atiyeh Asadpour et al. Stem Cell Research & Therapy
- Online marketing practices of regenerative medicine clinics in US-Mexico border region: a web surveillance study
- (2021) Javier Chavez et al. Stem Cell Research & Therapy
- Unproven stem cell interventions: A global public health problem requiring global deliberation
- (2021) Zubin Master et al. Stem Cell Reports
- The American stem cell sell in 2021: U.S. businesses selling unlicensed and unproven stem cell interventions
- (2021) Leigh Turner Cell Stem Cell
- Online seminars as an information source for direct-to-consumer stem cell therapy
- (2021) Mirna Hassoun et al. Regenerative Medicine
- Cell-based therapies for retinal diseases: a review of clinical trials and direct to consumer “cell therapy” clinics
- (2021) John W. Hinkle et al. Stem Cell Research & Therapy
- Weighing up the evidence used by direct-to-consumer stem cell businesses
- (2021) Margaret Cook et al. Stem Cell Reports
- Investigation of Bacterial Infections Among Patients Treated With Umbilical Cord Blood–Derived Products Marketed as Stem Cell Therapies
- (2021) Kathleen P. Hartnett et al. JAMA Network Open
- The biology, function, and biomedical applications of exosomes
- (2020) Raghu Kalluri et al. SCIENCE
- Clear Evidence of Safety and Efficacy Is Needed for Stromal Vascular Fraction Products: Commentary on “Arguments for a Different Regulatory Categorization and Framework for Stromal Vascular Fraction”
- (2020) Peter W. Marks STEM CELLS AND DEVELOPMENT
- Rogue stem cell clinics
- (2020) Iain R. Murray et al. Bone & Joint Journal
- Governmental Regulations and Increasing FDA Oversight of Regenerative Medicine Products: What's New in 2020?
- (2020) William Fang et al. ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY
- Identifying the Risks of Unproven Regenerative Medicine Therapies
- (2020) Peter W. Marks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Assessing “cell therapy” clinics offering treatments of ocular conditions using direct-to-consumer marketing websites in the United States
- (2019) Rajinder S. Nirwan et al. OPHTHALMOLOGY
- Characteristics and Scope of Training of Clinicians Participating in the US Direct-to-Consumer Marketplace for Unproven Stem Cell Interventions
- (2019) Wayne Fu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- How to Peddle Hope: An Analysis of YouTube Patient Testimonials of Unproven Stem Cell Treatments
- (2019) Bethany Hawke et al. Stem Cell Reports
- Characterizing Direct-to-Consumer Stem Cell Businesses in the Southwest United States
- (2019) Emma K. Frow et al. Stem Cell Reports
- Direct-to-Consumer Advertising of Stem Cell Clinics
- (2019) Christian A. Pean et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- Online Direct-to-Consumer Advertising of Stem Cell Therapy for Musculoskeletal Injury and Disease
- (2019) Matthew T. Kingery et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- Too Much Carrot and Not Enough Stick in New Stem Cell Oversight Trends
- (2018) Paul S. Knoepfler Cell Stem Cell
- Selling stem cells with tokens of legitimacy: An analysis of websites in Japan and Australia
- (2018) T. Lysaght et al. CYTOTHERAPY
- Balancing Safety and Innovation for Cell-Based Regenerative Medicine
- (2018) Peter Marks et al. NEW ENGLAND JOURNAL OF MEDICINE
- The FDA and the US direct-to-consumer marketplace for stem cell interventions: a temporal analysis
- (2018) Paul S Knoepfler et al. Regenerative Medicine
- Selling stem cell ‘treatments’ as research: prospective customer perspectives from crowdfunding campaigns
- (2018) Jeremy Snyder et al. Regenerative Medicine
- Direct-to-consumer marketing of stem cell interventions by Canadian businesses
- (2018) Leigh Turner Regenerative Medicine
- The deadly business of an unregulated global stem cell industry
- (2017) Tamra Lysaght et al. JOURNAL OF MEDICAL ETHICS
- Clarifying Stem-Cell Therapy’s Benefits and Risks
- (2017) Peter W. Marks et al. NEW ENGLAND JOURNAL OF MEDICINE
- ‘No one here's helping me, what do you do?’: addressing patient need for support and advice about stem cell treatments
- (2017) Claire Tanner et al. Regenerative Medicine
- Open for business: a comparative study of websites selling autologous stem cells in Australia and Japan
- (2017) Megan Munsie et al. Regenerative Medicine
- Marketing of unproven stem cell–based interventions: A call to action
- (2017) Douglas Sipp et al. Science Translational Medicine
- Global Distribution of Businesses Marketing Stem Cell-Based Interventions
- (2016) Israel Berger et al. Cell Stem Cell
- Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry
- (2016) Leigh Turner et al. Cell Stem Cell
- The Stem Cell Hard Sell: Report from a Clinic's Patient Recruitment Seminar
- (2016) Paul S. Knoepfler Stem Cells Translational Medicine
- Untested, unproven, and unethical: the promotion and provision of autologous stem cell therapies in Australia
- (2015) Alison K McLean et al. Stem Cell Research & Therapy
- Representations of Stem Cell Clinics on Twitter
- (2014) Kalina Kamenova et al. Stem Cell Reviews and Reports
- U.S. Regulation of Stem Cells as Medical Products
- (2012) D. Sipp et al. SCIENCE
- FDA Regulation of Stem Cell-Based Products
- (2009) D. W. Fink SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now